Clinical Study Results
Research Sponsor: AstraZeneca
Drugs Studied: Cediranib and olaparib
Study Title: A study to learn how cediranib and olaparib work together
in women with ovarian cancer, fallopian tube cancer, or
peritoneal cancer
Thank you!
Thank you for taking part in the clinical study for the study drugs cediranib and
olaparib. Cediranib is also called AZD2171, and olaparib is also called AZD2281.
You and all of the participants helped researchers learn more about these study
drugs to help people with ovarian cancer, fallopian tube cancer, or peritoneal
cancer.
AstraZeneca sponsored this study and thinks it is important to share the results
of the study with you and the public. An independent non-profit organization
called CISCRP helped prepare this summary of the study results for you. We
hope it helps you understand and feel proud of your important role in medical
research.
If you participated in the study and have questions about the results, please
speak with the doctor or staff at your study site.
1